Ha habido 50 transacciones internas recientes registradas para Tactile Systems Technology, Inc. (TCMD), incluyendo 26 compras y 21 ventas. El total de compras internas fue valorado en RSU Award y el total de ventas internas en $2M.
Internos destacados con actividad reciente incluyen Pearson Andrea, Dodd Sheri Louise, Burns Kristie. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — TCMD
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-03-09 |
Pearson Andrea |
Officer |
Desconocido |
- |
- |
- |
- |
| 2026-03-09 |
Pearson Andrea |
Director |
Concesión de RSU |
852 |
- |
- |
852 |
| 2026-02-24 |
Dodd Sheri Louise |
Chief Executive Officer |
Venta Informativa |
10,993 |
$28.94 |
$318.14K |
243,885 |
| 2026-02-24 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Venta Informativa |
6,246 |
$28.94 |
$180.76K |
82,581 |
| 2026-02-24 |
Birkemeyer Elaine M. |
Chief Financial Officer |
Venta Informativa |
7,701 |
$28.94 |
$222.88K |
134,819 |
| 2026-02-23 |
Dodd Sheri Louise |
Chief Executive Officer |
Venta Informativa |
537 |
$28.69 |
$15.41K |
254,878 |
| 2026-02-23 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Venta Informativa |
160 |
$28.69 |
$4.59K |
88,827 |
| 2026-02-23 |
Birkemeyer Elaine M. |
Chief Financial Officer |
Venta Informativa |
196 |
$28.69 |
$5.62K |
142,520 |
| 2026-02-20 |
Dodd Sheri Louise |
Chief Executive Officer |
Concesión de RSU |
19,751 |
- |
- |
241,902 |
| 2026-02-20 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Concesión de RSU |
3,490 |
- |
- |
82,085 |
| 2026-02-20 |
Birkemeyer Elaine M. |
Chief Financial Officer |
Concesión de RSU |
3,579 |
- |
- |
125,698 |
| 2026-02-19 |
Dodd Sheri Louise |
Chief Executive Officer |
Concesión de RSU |
48,672 |
- |
- |
222,151 |
| 2026-02-19 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Concesión de RSU |
6,194 |
- |
- |
78,595 |
| 2026-02-19 |
Birkemeyer Elaine M. |
Chief Financial Officer |
Concesión de RSU |
23,008 |
- |
- |
122,119 |
| 2026-01-02 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Venta Informativa |
5,139 |
$28.85 |
$148.26K |
72,401 |
| 2025-08-08 |
Dodd Sheri Louise |
Chief Executive Officer |
Venta Informativa |
7,762 |
$12.36 |
$95.91K |
173,479 |
| 2025-05-12 |
Birkemeyer Elaine M. |
Chief Financial Officer |
Venta Informativa |
2,921 |
$9.94 |
$29.04K |
99,111 |
| 2025-05-08 |
Burke William W |
Director |
Venta Informativa |
3,300 |
$9.67 |
$31.91K |
48,520 |
| 2025-05-08 |
Dodd Sheri Louise |
Chief Executive Officer |
Venta Informativa |
3,149 |
$9.83 |
$30.95K |
181,241 |
| 2025-05-07 |
Burke William W |
Director |
Concesión de RSU |
16,078 |
- |
- |
51,820 |
| 2025-05-07 |
Volkart Carmen B |
Director |
Concesión de RSU |
16,078 |
- |
- |
37,698 |
| 2025-05-07 |
Huggenberger Raymond |
Director |
Concesión de RSU |
16,078 |
- |
- |
56,320 |
| 2025-05-07 |
Shafer David Brent |
Director |
Concesión de RSU |
16,078 |
- |
- |
48,822 |
| 2025-05-07 |
Asbury Valerie L. |
Director |
Concesión de RSU |
16,078 |
- |
- |
48,822 |
| 2025-05-07 |
Washington Boyd Vindell |
Director |
Concesión de RSU |
16,078 |
- |
- |
35,247 |
| 2025-05-07 |
King Laura G. |
Director |
Concesión de RSU |
16,078 |
- |
- |
19,048 |
| 2025-03-11 |
Reuvers Daniel L. |
Director |
Donación (Recibida) |
68,162 |
- |
- |
68,162 |
| 2025-02-25 |
Reuvers Daniel L. |
Director |
Venta Informativa |
28,338 |
$14.18 |
$401.85K |
214,604 |
| 2025-02-25 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Venta Informativa |
6,468 |
$14.40 |
$93.16K |
77,540 |
| 2025-02-25 |
Birkemeyer Elaine M. |
Chief Financial Officer |
Venta Informativa |
2,066 |
$14.51 |
$29.98K |
102,032 |
| 2025-02-24 |
Reuvers Daniel L. |
Director |
Venta Informativa |
10,938 |
$14.55 |
$159.15K |
242,942 |
| 2025-02-24 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Venta Informativa |
4,830 |
$14.65 |
$70.75K |
84,008 |
| 2025-02-24 |
Birkemeyer Elaine M. |
Chief Financial Officer |
Venta Informativa |
3,778 |
$14.70 |
$55.54K |
104,098 |
| 2025-02-20 |
Reuvers Daniel L. |
Director |
Concesión de RSU |
15,853 |
- |
- |
253,880 |
| 2025-02-20 |
Dodd Sheri Louise |
Chief Executive Officer |
Concesión de RSU |
20,108 |
- |
- |
118,721 |
| 2025-02-20 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Concesión de RSU |
3,359 |
- |
- |
68,128 |
| 2025-02-20 |
Birkemeyer Elaine M. |
Chief Financial Officer |
Concesión de RSU |
3,446 |
- |
- |
64,741 |
| 2025-02-20 |
King Laura G. |
Director |
Concesión de RSU |
2,970 |
- |
- |
2,970 |
| 2025-01-13 |
King Laura G. |
Director |
Desconocido |
- |
- |
- |
- |
| 2024-08-12 |
Ferstler Sherri Lee |
Senior VP, Sales |
Venta Informativa |
1,550 |
$13.07 |
$20.26K |
38,764 |
| 2024-08-07 |
Dodd Sheri Louise |
Chief Executive Officer |
Concesión de RSU |
64,959 |
- |
- |
98,613 |
| 2024-05-16 |
Birkemeyer Elaine M. |
Chief Financial Officer |
Venta Informativa |
3,041 |
$13.68 |
$41.59K |
61,295 |
| 2024-05-08 |
Burke William W |
Director |
Venta Informativa |
2,500 |
$14.06 |
$35.15K |
25,273 |
| 2024-05-08 |
Volkart Carmen B |
Director |
Concesión de RSU |
10,469 |
- |
- |
21,620 |
| 2024-05-08 |
Huggenberger Raymond |
Director |
Concesión de RSU |
10,469 |
- |
- |
40,242 |
| 2024-05-08 |
Shafer David Brent |
Director |
Concesión de RSU |
10,469 |
- |
- |
32,744 |
| 2024-05-08 |
Dodd Sheri Louise |
Director |
Concesión de RSU |
10,469 |
- |
- |
33,654 |
| 2024-05-08 |
Asbury Valerie L. |
Director |
Concesión de RSU |
10,469 |
- |
- |
32,744 |
| 2024-05-08 |
Washington Boyd Vindell |
Director |
Concesión de RSU |
10,469 |
- |
- |
19,169 |
| 2024-05-06 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Venta Informativa |
815 |
$14.37 |
$11.71K |
62,574 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
